Mangalam Drugs and Organics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

169.02

217.82

214.79

218.98

200.67

Operating profit

-1.28

18.81

16.47

15.29

31.24

Interest

6.66

6.10

5.22

5.94

4.76

Gross profit

-7.89

12.72

19.29

18.69

27.82

EPS (Rs)

-8.27

3.30

6.77

5.65

12.25

Other income

0.05

0.01

8.04

9.34

1.34

Stock adjustment

-10.61

-21.35

-1.13

-32.62

-13.81

Raw material

126.56

155.41

150.78

188.30

147.78

Power and fuel

-

-

-

-

-

Employee expenses

18.99

18.90

20.33

16.93

14.00

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

35.37

46.05

28.35

31.09

21.46

Provisions made

-

-

-

-

-

Depreciation

7.15

5.36

5.36

4.89

4.33

Taxation

-1.94

2.13

3.22

4.86

4.11

Net profit / loss

-13.10

5.23

10.71

8.94

19.38

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

15.83

15.83

15.83

15.83

15.83

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-0.76

8.63

7.67

6.98

15.57

GPM (%)

-4.67

5.84

8.66

8.19

13.77

NPM (%)

-7.75

2.40

4.81

3.92

9.60